Wired for Relief: Assessing the Risks and Rewards of DBS in Treatment-Resistant Obsessive Compulsive Disorder

Obsessive-compulsive disorder (OCD) can be a lifelong and debilitating condition that can be resistant to pharmacological and psychotherapeutic treatments. Over the last couple of decades, the emergence of deep brain stimulation (DBS) has been proven as an effective form of treatment for patients with movement disorders such as Parkinson’s disease, and even for patients with epilepsy. With the previous success of DBS, this neurosurgical intervention has now also become a promising form of treatment for patients suffering from treatment-resistant OCD. But with its newness, its efficacy, safety, and long-term success remain under evaluation. The goal of this review is to evaluate, assess, and discuss the sustained long-term effectiveness, ideal target locations, risks, and safety, including suicide rates, and compare DBS to more non-invasive forms of treatment such as TMS (transcranial magnetic stimulation). The results showed that, after treatment, patients experienced a significant reduction in their mean Y-BOCS score.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-20
DOI
https://doi.org/10.5281/zenodo.16222883
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Wired for Relief: Assessing the Risks and Rewards of DBS in Treatment-Resistant Obsessive Compulsive Disorder

Zenodo (CERN European Organization for Nuclear Research)
Neurological disorders and treatments
article

Wired for Relief: Assessing the Risks and Rewards of DBS in Treatment-Resistant Obsessive Compulsive Disorder

article en

Abstract

Obsessive-compulsive disorder (OCD) can be a lifelong and debilitating condition that can be resistant to pharmacological and psychotherapeutic treatments. Over the last couple of decades, the emergence of deep brain stimulation (DBS) has been proven as an effective form of treatment for patients with movement disorders such as Parkinson’s disease, and even for patients with epilepsy. With the previous success of DBS, this neurosurgical intervention has now also become a promising form of treatment for patients suffering from treatment-resistant OCD. But with its newness, its efficacy, safety, and long-term success remain under evaluation. The goal of this review is to evaluate, assess, and discuss the sustained long-term effectiveness, ideal target locations, risks, and safety, including suicide rates, and compare DBS to more non-invasive forms of treatment such as TMS (transcranial magnetic stimulation). The results showed that, after treatment, patients experienced a significant reduction in their mean Y-BOCS score.

Zenodo (CERN European Organization for Nuclear Research)
The University of Texas at Dallas (US), Global University (LB)
Good health and well-being
Openalex Percentile: Top 40%
Neurological disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Wired for Relief: Assessing the Risks and Rewards of DBS in Treatment-Resistant Obsessive Compulsive Disorder · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS